✦ LIBER ✦

Expanded Carrier Screening in the Ashkenazi Jewish Population

✍ Scribed by John Mitchell

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 71 KB
Volume: 31
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.21381

No coin nor oath required. For personal study only.

✦ Synopsis

Alas, classical genetics again has insulted my sense of human genomic superiority. August 2010 saw the publication of the genome sequence of the demosponge

📜 SIMILAR VOLUMES

Tay-Sachs screening in the Jewish Ashken

Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure

✍ Bach, Gideon ;Tomczak, Jerzy ;Risch, Neil ;Ekstein, Josef 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Screening for carriers of Tay-Sachs dise

Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel

✍ Broide, Etty ;Zeigler, Marcia ;Eckstein, Joseph ;Bach, Gideon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

A screening program for the detection of Tay-Sachs disease (TSD) carriers in the ultra Orthodox community of Ashkenazi J e w s has operated in Israel since 1986. The purpose of this program is the prevention of marriages of 2 heterozygotes. The screened individuals are mostly couples in the engageme

Experience with carrier screening and pr

Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases

✍ Stuart A. Scott; Lisa Edelmann; Liu Liu; Minjie Luo; Robert J. Desnick; Ruth Kor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

The success of prenatal carrier screening as a disease prevention strategy in the Ashkenazi Jewish (AJ) population has driven the expansion of screening panels as disease-causing founder mutations have been identified. However, the carrier frequencies of many of these mutations have not been reporte

Prevalence of glucocerebrosidase mutatio

Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population

✍ Mia Horowitz; Metsada Pasmanik-Chor; Zvi Borochowitz; Tzipora Falik-Zaccai; Kere 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

Gaucher disease is the most prevalent inherited disease among Ashkenazi Jews. It is very heterogeneous due to a large number of mutations within the glucocerebrosidase gene, whose impaired activity is the cause for this disease. Aiming at determining Gaucher carrier frequency among the Ashkenazi Jew

Type 2 diabetes susceptibility loci in t

Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population

✍ Michal Bronstein; Anne Pisanté; Benjamin Yakir; Ariel Darvasi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 266 KB

The Ashkenazi Jewish Fanconi anemia muta

The Ashkenazi Jewish Fanconi anemia mutation: Incidence among patients and carrier frequency in the at-risk population

✍ Michael A. Whitney; Petra Jakobs; Michael Kaback; Robb E. Moses; Markus Grompe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

## Communicared by Edward R. B. McCabe Fanconi anemia (FA) is an autosomal recessive disease for which at least four complementation groups exist. Recently the gene that corrects the defect in Fanconi anemia complementation group C cells (FACC) has been cloned. We have previously identified a comm